These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31744014)

  • 1. Responsiveness to Change Over Time: An Examination of the Neuro-QoL Social Function Measures in Persons with Huntington's Disease.
    Carlozzi NE; Boileau NR; Hahn EA; Barton SK; Cella D; McCormack MK; Ready RE
    J Huntingtons Dis; 2020; 9(1):83-97. PubMed ID: 31744014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responsiveness to change over time and test-retest reliability of the PROMIS and Neuro-QoL mental health measures in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Roché MW; Ready RE; Perlmutter JS; Chou KL; Barton SK; McCormack MK; Stout JC; Cella D; Miner JA; Paulsen JS
    Qual Life Res; 2020 Dec; 29(12):3419-3439. PubMed ID: 32813263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDQLIFE and neuro-QoL physical function measures: Responsiveness in persons with huntington's disease.
    Carlozzi NE; Boileau NR; Chou KL; Ready RE; Cella D; McCormack MK; Miner JA; Dayalu P
    Mov Disord; 2020 Feb; 35(2):326-336. PubMed ID: 31724237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.
    Carlozzi NE; Hahn EA; Goodnight SM; Kratz AL; Paulsen JS; Stout JC; Frank S; Miner JA; Cella D; Gershon RC; Schilling SG; Ready RE
    Psychol Assess; 2018 Apr; 30(4):450-458. PubMed ID: 28557480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychometric properties and responsiveness of Neuro-QoL Cognitive Function in persons with Huntington disease (HD).
    Carlozzi NE; Boileau NR; Paulsen JS; Downing NR; Ready R; Perlmutter JS; Cella D; Chou KL; McCormack MK; Barton S; Lai JS
    Qual Life Res; 2020 May; 29(5):1393-1403. PubMed ID: 31853881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.
    Carlozzi NE; Goodnight S; Kratz AL; Stout JC; McCormack MK; Paulsen JS; Boileau NR; Cella D; Ready RE
    J Huntingtons Dis; 2019; 8(4):467-482. PubMed ID: 31424415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.
    Boileau NR; Stout JC; Paulsen JS; Cella D; McCormack MK; Nance MA; Frank S; Lai JS; Carlozzi NE
    J Huntingtons Dis; 2017; 6(3):201-215. PubMed ID: 28968239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.
    Lai JS; Goodnight S; Downing NR; Ready RE; Paulsen JS; Kratz AL; Stout JC; McCormack MK; Cella D; Ross C; Russell J; Carlozzi NE
    Qual Life Res; 2018 Mar; 27(3):811-822. PubMed ID: 29222609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient-reported outcomes in Huntington's disease: Quality of life in neurological disorders (Neuro-QoL) and Huntington's disease health-related quality of life (HDQLIFE) physical function measures.
    Carlozzi NE; Ready RE; Frank S; Cella D; Hahn EA; Goodnight SM; Schilling SG; Boileau NR; Dayalu P
    Mov Disord; 2017 Jul; 32(7):1096-1102. PubMed ID: 28556412
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data.
    Tabrizi SJ; Scahill RI; Owen G; Durr A; Leavitt BR; Roos RA; Borowsky B; Landwehrmeyer B; Frost C; Johnson H; Craufurd D; Reilmann R; Stout JC; Langbehn DR;
    Lancet Neurol; 2013 Jul; 12(7):637-49. PubMed ID: 23664844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive Affect and Well-Being in Huntington's Disease Moderates the Association Between Functional Impairment and HRQOL Outcomes.
    Ready RE; Boileau NR; Barton SK; Lai JS; McCormack MK; Cella D; Fritz NE; Paulsen JS; Carlozzi NE
    J Huntingtons Dis; 2019; 8(2):221-232. PubMed ID: 31045519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?
    Carlozzi NE; Schilling S; Kratz AL; Paulsen JS; Frank S; Stout JC
    Qual Life Res; 2018 Oct; 27(10):2541-2555. PubMed ID: 29909483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data.
    Tabrizi SJ; Reilmann R; Roos RA; Durr A; Leavitt B; Owen G; Jones R; Johnson H; Craufurd D; Hicks SL; Kennard C; Landwehrmeyer B; Stout JC; Borowsky B; Scahill RI; Frost C; Langbehn DR;
    Lancet Neurol; 2012 Jan; 11(1):42-53. PubMed ID: 22137354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.
    Fritz NE; Boileau NR; Stout JC; Ready R; Perlmutter JS; Paulsen JS; Quaid K; Barton S; McCormack MK; Perlman SL; Carlozzi NE;
    J Neuropsychiatry Clin Neurosci; 2018; 30(3):194-201. PubMed ID: 29558861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDQLIFE: development and assessment of health-related quality of life in Huntington disease (HD).
    Carlozzi NE; Schilling SG; Lai JS; Paulsen JS; Hahn EA; Perlmutter JS; Ross CA; Downing NR; Kratz AL; McCormack MK; Nance MA; Quaid KA; Stout JC; Gershon RC; Ready RE; Miner JA; Barton SK; Perlman SL; Rao SM; Frank S; Shoulson I; Marin H; Geschwind MD; Dayalu P; Goodnight SM; Cella D
    Qual Life Res; 2016 Oct; 25(10):2441-2455. PubMed ID: 27522213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and Calibration of the TBI-QOL Ability to Participate in Social Roles and Activities and TBI-QOL Satisfaction With Social Roles and Activities Item Banks and Short Forms.
    Heinemann AW; Kisala PA; Boulton AJ; Sherer M; Sander AM; Chiaravalloti N; Bushnik T; Hanks R; Roth E; Tulsky DS
    Arch Phys Med Rehabil; 2020 Jan; 101(1):20-32. PubMed ID: 31473208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The development of a new computer adaptive test to evaluate chorea in Huntington disease: HDQLIFE Chorea.
    Carlozzi NE; Downing NR; Schilling SG; Lai JS; Goodnight SM; Miner JA; A Frank S
    Qual Life Res; 2016 Oct; 25(10):2429-2439. PubMed ID: 27141833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease.
    Seibert TM; Majid DS; Aron AR; Corey-Bloom J; Brewer JB
    Neuroimage; 2012 Feb; 59(3):2452-63. PubMed ID: 21945695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
    Winder JY; Achterberg WP; Gardiner SL; Roos RAC
    Eur J Neurol; 2019 May; 26(5):780-785. PubMed ID: 30576046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuro-QoL health-related quality of life measurement system: Validation in Parkinson's disease.
    Nowinski CJ; Siderowf A; Simuni T; Wortman C; Moy C; Cella D
    Mov Disord; 2016 May; 31(5):725-33. PubMed ID: 26919664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.